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Repeat sequence motifs as well as unique sequences between nucleotides -150 and -22 of the human
cytomegalovirus immediate-early 1 gene interact in vitro with nuclear proteins. We show that a transcriptional
element between nucleotides -91 and -65 stimulated promoter activity in vivo and in vitro by binding specific
cellular transcription factors. Finally, a common sequence motif, (T)TGG/AC, present in 15 of the determined
binding sites suggests a particular class of nuclear factors associated with the immediate-early 1 gene.
The regulatory region of the human cytomegalovirus
(HCMV) immediate-early 1 (IE1) gene contains several
different functional domains. These include polymerase II
promoter, enhancer, and repressor activities. The function
of these regulatory domains has been shown in in vitro and
in vivo expression systems (2, 9, 11, 12). A remarkable
feature of the IE1 regulatory region is its complex repetitive
sequence composition. Our previous experiments have
shown that the enhancer domain, between nucleotides -524
and -185, interacts with specific transcription factors which
recognize several of the repeated sequence motifs as well as
a unique sequence (4). However, it was not clear and cannot
be assumed from this study that repeat sequences, and in
particular sequences outside the repeats, downstream of
-185 bind specific transcription factors. Therefore, we have
investigated the ability of DNA-binding proteins in transcrip-
tionally active HeLa cell nuclear extract to interact with
specific target sequences in the IEl promoter-regulatory
region.
Nuclear and S100 extracts from HeLa cells were prepared
(3), and the nuclear extract was chromatographically frac-
tionated as shown in Fig. 1A. We determined specific
DNA-protein interactions by performing a mobility shift
assay as described (8). The fragment (E3) between nucleo-
tides -185 and -14 incubated with crude nuclear extract
resulted in several distinct nucleoprotein complexes, sug-
gesting the binding of multiple factors (Fig. 1B, lane 2). The
cytoplasmic (S100) fraction did not contain significant bind-
ing activity (Fig. 1B, lane 3), confirming that the binding
proteins were of nuclear origin. The various protein fractions
obtained after fractionation of the crude nuclear extract also
resulted in a complex band shift pattern (Fig. 1B). To
delineate precisely at the nucleotide level sites of protein-
DNA interaction, DNase I protection analyses were per-
formed (Fig. 2) as described (4, 10). In two respects, these
data are in agreement with the mobility shift experimental
results. First, protected regions were observed in only those
column fractions which developed specific band shift pat-
terns. Second, multiple regions of protection were observed,
which can explain the complex band shift pattern.
Four principal regions of protection were observed on the
HCMV IEl promoter-regulatory sequence between nucleo-
tides -50 and -146 (Fig. 2; see Fig. 4). Interestingly, clear
protection for the 18-base-pair (bp) repeat between nucleo-
tides -172 and -155 was not observed, while that between
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nucleotides -109 and -92 was protected (Fig. 2). Immedi-
ately flanking and partly overlapping the 5' end of this latter
repeat was a strong binding site from nucleotides -120 to
-107. The binding activity of this site could not be competed
for by the simian virus 40 or human immunodeficiency virus
enhancer elements (unpublished), which have sequence ho-
mologies with the 18-bp repeats (2, 4). This observation
supports the suggestion that this sequence represents a
unique binding site. In proximity to this binding site (be-
tween nucleotides -146 and -129) is a 19-bp repeat element
that was clearly protected, in agreement with our previous
observations for the other 19-bp repeats (4). All of these
described binding sites were situated within the functionally
characterized enhancer-regulatory domain (2, 11). A redun-
dant form of the 19-bp palindromic repeat between nucleo-
tides -70 and -58 (83% homology), in which the symmetry
has been disrupted, was located within a weakly protected
region. Additional confirmation of a factor capable of bind-
ing to this site was obtained after enrichment of the factor
with a single-stranded DNA-cellulose column (data not
shown). The binding property (degree of protection) of this
site was clearly different from that of the other 19-bp repeats
(Fig. 2) (4). We cannot at present distinguish between the
possibilities that this factor is identical to or different from
the factor binding to other 19-bp repeat elements. It is
interesting that DNase I protection assays with mammary
gland extract (see below) did not show protection of the
19-bp repeat elements within the characterized enhancer
domain (2) but did show protection for the -70 to -50 region
(Fig. 2) (unpublished). Binding sites further downstream of
-50 were not detected with HeLa cell extract in the DNase
I protection experiments. However, in vitro transcription
competition experiments with the E3 fragment as specific
competitor (see below) (4) indicated that additional trans-
acting factors possibly interacted with sequences down-
stream of -50.
FIG. 1. (A) Schematic representation of the fractionation of
crude nuclear extract. The buffer used in all chromatographic steps
was buffer A (25 mM HEPES [N-2-hydroxyethylpiperazine-N'-2-
ethanesultonic acid, pH 7.9], 0.1 mM EDTA, 10% glycerol, 1 mM
DTT, and KCl as indicated). HeLa cell nuclear extract (80 mg) was
loaded on a 6.5-ml heparin-agarose (Bio-Rad) column equilibrated
with buffer A and 0.1 M KCl. The column was washed with 0.1 M
KCI in buffer A, followed by a step wash with 0.4 M KCI in buffer
A. The proteins eluted with 0.4 M KCI (HAO.4 fraction) were
dialyzed against 0.1 M KCI in buffer A. The HAO.4 fraction was
applied to a 3.5-ml DEAE-Sepharose CL-6B (Pharmacia) column
equilibrated with 0.1 M KCI in buffer A. The flowthrough fraction
(DEO.1 fraction) was collected, and thereafter the column was
washed with 0.1 M KCI in buffer A. The column was then step
washed with 0.225 M KCI in buffer A, and the collected fraction
(DEO.225 fraction) was dialyzed against 0.1 M KCI in buffer A. The
DEO.1 fraction was applied to a 3.5-ml phosphocellulose (P11;
Whatman) column eqilibrated with 0.1 M KCI in buffer A and
washed with 0.1 M, 0.3 M, 0.6 M, and 1 M KCI, successively. Each
step-washed fraction (fractions P110.3, P110.6, and P1ll) was
dialyzed against 0.1 M KCI in buffer A. (B) Mobility shift complexes
formed with nuclear proteins and sequences between nucleotides
-185 and -14. The labeled E3 fragment (0.2 ng) and 1 pLg of
poly(dI-dC) were incubated with 1 p.g of different protein fractions.
Lane 1, probe in the absence of protein; lane 2, crude nuclear
extract; lane 3, S100 fraction; lane 4, HAO.1 fraction; lane 5, HAO.4
fraction; lane 6, DEO.1 fraction; lane 7, DEO.225 fraction; lane 8,
P110.3 fraction; lane 9, P110.6 fraction; lane 10, P1ll fraction.
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FIG. 2. Binding of nuclear proteins to the IEl promoter as
determined by DNase I protection. The NcoI-XbaI (-220 to +55)
fragment was derived from pCMV(-524)CAT (4) and labeled at the
5' ends with T4 polynucleotide kinase and [y-32P]ATP. The XbaI site
at +55 was created by the addition of a polylinker to the HpaII site
at +55 of the IE1 gene. Protection of the upper (left panel) and lower
(right panel) strand of the NcoI (-220) to XbaI (+55) fragment is
shown. Lanes M, A/G Maxam and Gilbert sequencing reaction of
the respective fragment. Lanes C, DNase I digestion products of the
DNA fragments in the presence of bovine serum albumin. Lanes 1,
15 RI of HAO.4; lanes 2, 25 R1 of DEO.1; lanes 3, 25 ,u1 of DE0.225;
lanes 4, 25 ,u1 of P110.3; lanes 5, 25 ,ul of P110.6; lanes 6, 25 ,u1 of
P111; lanes 7, 6 pu1 of crude nuclear extract from lactating rat
mammary glands (MG). Nuclear extract from the rat mammary
gland was prepared as described (6). Arrows mark the positions of
protein-induced DNase I-hypersensitive sites. Brackets indicate
protected regions. Numbers refer to the nucleotide position with
respect to the start site of transcription.
A plausible explanation for these apparently conflicting
observations is that such trans-acting factors are a minor
component of the HeLa cell nuclear extract and their detec-
tion is made possible by the extreme sensitivity of the
transcription assay. In this connection, we asked whether
these sequences had the ability to interact with nuclear
proteins prepared from different sources. We found that
mammary gland nuclear extract, similar to the HeLa cell
extract, protected sequences between nucleotides -146 and
-50. The exact boundaries of the protected regions were not
the same as in HeLa extract, and additional hypersensitive
sites were observed (Fig. 2, lanes 7). Moreover, HCMV IE1
promoter sequences between -50 and -22 were clearly
protected with mammary gland extract. This observation
supports the suggestion that these sequences can interact
with specific nuclear factors.
Since we detected different binding properties between
those 19-bp repeat elements within the characterized en-
hancer and that from -73 to -54, we asked whether
sequences in this region could activate transcription from the
promoter. Therefore, we tested two plasmids that specifi-
cally truncate the IE1 5'-flanking region at positions -91
[pCMV(-91)CAT] and -65 [pCMV(-65)CAT] in in vivo
and in vitro expression systems. The template pCMV(-65)
CAT directed a low but detectable level of transcription
upon transient expression in HeLa cells, whereas
pCMV(-91)CAT resulted in a 10-fold higher level of tran-
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FIG. 3. Expression of the HCMV lEl promoter in vivo and in
vitro. Plasmids pCMV(-91)CAT and pCMV(-65)CAT were ob-
tained from R. Ruger and B. Fleckenstein. These plasmids contain
5' deletion fragments of the HCMV (strain AD169) IEl gene linked
to the chloramphenicol acetyltransferase (CAT) gene. Transfections
were performed by the DEAE-dextran method (1). Cell extract was
prepared, and CAT activity was determined by the method of
Gorman et al. (5). (A) CAT activity directed by plasmids
pCMV(-91)CAT (lane 1), pCMV(-65)CAT (lane 2), and pCATO
(lane 3) after transient expression in HeLa cells. Chloramphenicol
(CM) and its acetylated forms 1-acetate (CM-1-AC) and 3-acetate
(CM-3-AC) were detected by autoradiography. Quantitation of CAT
activity was determined by scintillation counting. (B) RNA synthe-
sized in vitro from the templates pCMV(-91)CAT (lane 1) and
pCMV(-65)CAT (lane 2), both of which had been truncated with
PvuII. In vitro transcription reactions were performed as described
(4). The 220-nucleotide transcript marked by an arrow initiated at
the IEl mRNA start site used in vivo and terminated at the PvuIl
site in the cat gene. Transcriptional activity was determined by
densitometric scanning of autoradiographs. (C) RNA synthesized
from templates pCMV(-91)CAT (lanes 1 to 3) and pCMV(-65)CAT
(lanes 4 to 6) after preincubating the nuclear extract with competitor
DNA. The conditions of the in vitro transcription competition
reactions were the same as described previously (4). A 15-fold
excess of the following competitors was used: pUC19 cut with
HaeIII (lanes 1 and 4), fragment El covering IEi enhancer sequence
between nucleotides -524 and -311 (lanes 2 and 5), and fragment
E3 covering IEl enhancer-promoter sequences between nucleotides
-185 and -14 (lanes 3 and 6). The DNA fragments El and E3 were
gel purified from their respective plasmids, pEi and pE3 (4), after
cleaving with the restriction endonucleases EcoRI and Hindlll. The
arrow marks the IEi promoter-specific transcript.
scription (Fig. 3A). In agreement with this, runoff in vitro
transcription analysis of these plasmids resulted in approxi-
mately 5- to 10-fold more specific transcript molecules from
pCMV(-91)CAT than from the pCMV(-65)CAT template
(Fig. 3B). Thus, in two indepedent assay systems, a promot-
er-proximal transcription regulatory sequence between -91
and -65 of the IEl gene was functional in vivo and in
vitro.
To determine whether the transcriptional stimulation me-
diated by these sequences involved the binding of trans-
acting factors, we used an in vitro transcription competition
assay (4). The same extract and DNA template preparations
were assayed in the presence of nonspecific DNA and
fragment E3 (-185 to -14) as specific competitor. The
activity of the IEl promoter in pCMV(-91)CAT and
pCMV(-65)CAT was reduced below the basal level of
transcription in the presence of specific competitor (Fig. 3C,
lanes 1, 3, 4, and 6). This observation suggests that the
transcriptional activities of both pCMV(-91)CAT and
pCMV(-65)CAT involve the interaction of specific trans-
acting factors. To examine whether the stimulatory activity
of sequences present in pCMV(-91)CAT was associated
with enhancer elements, competition assays were performed
with an IEl enhancer-specific fragment. Transcriptional
stimulation of the IEl promoter in pCMV(-91)CAT but not
in pCMV(-65)CAT was selectively reduced by the enhancer
sequences between -524 and -311 (Fig. 3C, lanes 2 and 5).
The reduction of transcriptional activity of pCMV(-91)CAT
to about the level observed with pCMV(-65)CAT suggests
that a common or closely related trans-acting factor(s)
interacted with the IEl enhancer and upstream promoter
sequences. Furthermore, this suggests that the enhancer
domain extends to nucleotides between -91 and -65.
Three lines of evidence support the conclusion that the
-70 to -50 region is important for stimulating transcription
from the IEl promoter. The El fragment contains two 19-bp
palindromic repeats which showed homology with the se-
quence between -70 and -50 and competed effectively for
transcriptional stimulation in the in vitro competition exper-
iments; the transcriptionally active HeLa cell nuclear extract
contained a factor(s) which specifically interacted with the
-70 to -50 region; and the intact 5' half of the protected
palindromic sequence was deleted in pCMV(-65)CAT,
which showed reduced transcriptional activity in vivo and in
vitro (Fig. 4).
In summary, on the basis of this work and our previous
experiments (4), we are able to conclude the following.
Most, but not all, of the repetitive sequences which have
been implicated in the activity of the enhancer (2, 11) are
targets for specific transcription factors. The extent of pro-
tection for a repetitive sequence varies within members of a
class of repeat elements (e.g., 19-bp repeats) as well as
between different classes of repeat elements (e.g., 17- and
18-bp repeats). We show that sequences outside the repeat
elements, between nucleotides -445 to -425 and -120 to
-107, were also targets for specific nuclear proteins, further
increasing the order of complexity of this region. The 5'-end
half of 15 of the binding sites thus far determined (4, 6, 7; this
work) have a common sequence motif, (T)TG(G/A)C, which
may suggest a particular class of nuclear factors associated
with the HCMV IBE gene.
We thank Rudiger Ruger and Bernhard Fleckenstein for providing
plasmids pCMV(-91)CAT and pCMV(-65)CAT and William Ja-
koby for generous support and comments on the manuscript.
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FIG. 4. Sites of protein-DNA interaction on the HCMV IEl promoter. The DNA sequence of both strands is shown. Numbers represent
the distance (in base pairs) upstream of the transcription start site (+1). Sequences protected from DNase I cleavage by HeLa cell nuclear
proteins are marked by white letters on black background (strong protection) or by a hatched box (weak protection). Vertical arrows mark
positions of enhanced protein-induced DNase I cleavage in vitro. Large open arrows indicate the 5' endpoints of pCMV(-91)CAT and
pCMV(-65)CAT. The horizontal arrow marks the 19-bp repeat element, and solid dots indicate the 18-bp repeat element (enhancer core).
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